6FK.F 3.24 (-0.61%)
NO0010748866Medical Diagnostics & ResearchDiagnostics & Research

Gentian Diagnostics (6FK.F) Competitor Comparison

We are evaluating the key criteria listed to compare Gentian Diagnostics (6FK.F) against its competitors in the Diagnostics & Research industry.

Performance 5 years - 6FK.F ranking 0 / 58

These are the competitors of Gentian Diagnostics in the industry Diagnostics & Research ranked by performance 5 years
1. Natera NTRA
343.02
2. Lantheus Holdings LNTH
323.18
3. Medpace Holdings MEDP
303.78
4. RadNet RDNT
282.43
5. Meridian Bioscience VIVO
118.46
6. Twist Bioscience TWST
100.08
7. Danaher DHR
70.66
8. DarioHealth DRIO
61.4
9. IDEXX Laboratories IDXX
60.05
10. Thermo Fisher Scientific TMO
59.57
11. Agilent Technologies A
58.36
12. Waters WAT
57.66
13. Laboratory Corp of America Holdings LH
56.99
14. Mettler-Toledo MTD
55.01
15. PerkinElmer PKI
48.44
16. DexCom DXCM
47.4
17. Quest Diagnostics DGX
41.05
18. Fulgent Genetics FLGT
34.06
19. IQVIA Holdings IQV
30.76
20. Charles River Laboratories CRL
23.44
21. Icon ICLR
22.53
22. Ortho Clinical Diagnostics Holdings OCDX
13.74
23. Heska HSKA
12.14
24. Qiagen QGEN
8.42
25. Co-Diagnostics CODX
6.45
26. Inotiv NOTV
-1.21
27. Anixa Biosciences ANIX
-6.27
28. CareDx CDNA
-9.8
29. Syneos Health SYNH
-16.98
30. Olink Holding OLK
-26.82
31. Bioventus BVS
-29.34
32. Exact Sciences EXAS
-38.67
33. Interpace Biosciences IDXG
-40.83
34. NeoGenomics NEO
-40.99
35. Sera Prognostics SERA
-41.51
36. Personalis PSNL
-41.92
37. Myriad Genetics MYGN
-50.88
38. Sotera Health SHC
-50.96
39. Illumina ILMN
-57.21
40. Guardant Health GH
-61.34
41. Pacific Biosciences of California PACB
-64.38
42. Enzo Biochem ENZ
-65.26
43. Neogen NEOG
-65.54
44. National Research NRC
-73.6
45. MaxCyte MXCT
-75.04
46. Exagen XGN
-76.2
47. Psychemedics PMD
-78.68
48. Trinity Biotech TRIB
-81.02
49. MDxHealth MDXH
-81.4
50. Global Cord Blood CO
-86.47
51. Precipio PRPO
-88.08
52. Biodesix BDSX
-88.45
53. bioAffinity Technologies BIAF
-88.45
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.29

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.